GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surgalign Holdings Inc (OTCPK:SRGAQ) » Definitions » Piotroski F-Score

Surgalign Holdings (Surgalign Holdings) Piotroski F-Score : 3 (As of Apr. 28, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Surgalign Holdings Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Surgalign Holdings has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Surgalign Holdings's Piotroski F-Score or its related term are showing as below:

SRGAQ' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 4   Max: 7
Current: 3

During the past 13 years, the highest Piotroski F-Score of Surgalign Holdings was 7. The lowest was 2. And the median was 4.


Surgalign Holdings Piotroski F-Score Historical Data

The historical data trend for Surgalign Holdings's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surgalign Holdings Piotroski F-Score Chart

Surgalign Holdings Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 3.00 3.00 4.00 3.00

Surgalign Holdings Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 3.00 4.00 3.00 3.00

Competitive Comparison of Surgalign Holdings's Piotroski F-Score

For the Medical Devices subindustry, Surgalign Holdings's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surgalign Holdings's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Surgalign Holdings's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Surgalign Holdings's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar23) TTM:Last Year (Mar22) TTM:
Net Income was -5.688 + -9.833 + -39.111 + 4.145 = $-50.49 Mil.
Cash Flow from Operations was -13.271 + -13.379 + -6.321 + -9.022 = $-41.99 Mil.
Revenue was 20.623 + 20.178 + 20.573 + 16.748 = $78.12 Mil.
Gross Profit was 14.209 + 14.692 + -2.808 + 10.674 = $36.77 Mil.
Average Total Assets from the begining of this year (Mar22)
to the end of this year (Mar23) was
(121.545 + 105.697 + 88.043 + 70.242 + 67.712) / 5 = $90.6478 Mil.
Total Assets at the begining of this year (Mar22) was $121.55 Mil.
Long-Term Debt & Capital Lease Obligation was $10.24 Mil.
Total Current Assets was $53.43 Mil.
Total Current Liabilities was $19.98 Mil.
Net Income was -16.192 + -7.906 + -45.362 + 0.027 = $-69.43 Mil.

Revenue was 24.834 + 20.545 + 21.83 + 20.605 = $87.81 Mil.
Gross Profit was 17.605 + 13.734 + 12.333 + 14.195 = $57.87 Mil.
Average Total Assets from the begining of last year (Mar21)
to the end of last year (Mar22) was
(144.243 + 169.81 + 156.743 + 123.799 + 121.545) / 5 = $143.228 Mil.
Total Assets at the begining of last year (Mar21) was $144.24 Mil.
Long-Term Debt & Capital Lease Obligation was $10.03 Mil.
Total Current Assets was $101.31 Mil.
Total Current Liabilities was $28.35 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Surgalign Holdings's current Net Income (TTM) was -50.49. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Surgalign Holdings's current Cash Flow from Operations (TTM) was -41.99. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar22)
=-50.487/121.545
=-0.41537702

ROA (Last Year)=Net Income/Total Assets (Mar21)
=-69.433/144.243
=-0.48136131

Surgalign Holdings's return on assets of this year was -0.41537702. Surgalign Holdings's return on assets of last year was -0.48136131. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Surgalign Holdings's current Net Income (TTM) was -50.49. Surgalign Holdings's current Cash Flow from Operations (TTM) was -41.99. ==> -41.99 > -50.49 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar22 to Mar23
=10.244/90.6478
=0.11300881

Gearing (Last Year: Mar22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar21 to Mar22
=10.034/143.228
=0.07005613

Surgalign Holdings's gearing of this year was 0.11300881. Surgalign Holdings's gearing of last year was 0.07005613. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar23)=Total Current Assets/Total Current Liabilities
=53.43/19.984
=2.67363891

Current Ratio (Last Year: Mar22)=Total Current Assets/Total Current Liabilities
=101.306/28.346
=3.57390814

Surgalign Holdings's current ratio of this year was 2.67363891. Surgalign Holdings's current ratio of last year was 3.57390814. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Surgalign Holdings's number of shares in issue this year was 13.32. Surgalign Holdings's number of shares in issue last year was 5.911. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=36.767/78.122
=0.47063567

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=57.867/87.814
=0.65897237

Surgalign Holdings's gross margin of this year was 0.47063567. Surgalign Holdings's gross margin of last year was 0.65897237. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar22)
=78.122/121.545
=0.64274137

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar21)
=87.814/144.243
=0.60879211

Surgalign Holdings's asset turnover of this year was 0.64274137. Surgalign Holdings's asset turnover of last year was 0.60879211. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+0+0+0+0+1
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Surgalign Holdings has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Surgalign Holdings  (OTCPK:SRGAQ) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Surgalign Holdings Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Surgalign Holdings's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Surgalign Holdings (Surgalign Holdings) Business Description

Traded in Other Exchanges
N/A
Address
520 Lake Cook Road, Suite 315, Deerfield, IL, USA, 60015
Surgalign Holdings Inc is a global medical technology company advancing the science of spine care, focused on delivering innovative solutions that drive superior clinical and economic outcomes. The company continues to invest in clinically validated innovation to deliver the Best surgical outcomes and improve patient's lives. It markets products throughout the United States and in more than 50 countries worldwide through an expanding network of top independent distributors. The U.S. market accounts for the vast majority of revenue. It has commercial and design centers in San Diego, California, and Wurmlingen, Germany.
Executives
Elizabeth A. Lapuma director 520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Jill Kathleen Frizzley director P.O. BOX 1541, ONE BLUE HILL PLAZA, PEARL RIVER NY 10965
Paolo Amoruso officer: Chief Legal Officer C/O HYPERDYNAMICS CORPORATION, 12012 WICKCHESTER LANE, SUITE 475, HOUSTON TX 77079
David Lyle officer: Chief Financial Officer 6290 SEQUENCE DRIVE, SAN DIEGO CA 92121
Marc E. Mackey officer: EVP, Digital Surgery 520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Terry M. Rich officer: President, Global Spine 520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
William Scott Durall officer: Chief Commercial Officer 520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Christopher Thunander officer: Chief Accounting Officer 520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Thomas Mceachin director 11621 RESEARCH CIRCLE, ALACHUA FL 32615
Nicholas J Valeriani director C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Sheryl L Conley director C/O NEURONETICS, INC., 3222 PHOENIXVILLE PIKE, MALVERN PA 19355
Enrico Sangiorgio officer: EVP, International 520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Stuart F. Simpson director 520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Pawel Lewicki director 296 WOODWARD BLVD., TULSA OK 74114
Jeffrey C Lightcap director 152 W 57TH STREET 43RD FLOOR, NEW YORK NY 10019